{"version":"1.0","type":"link","title":"First-line treatment efficacy of anti-EGFR versus anti-VEGF antibodies in BRAF-mutated metastatic colorectal cancer according to primary tumor sidedness: A pooled analysis of seven clinical trials performed in the first-line treatment of mCRC (German AIO Study Group).","author_name":"Weiss L 외","author_url":"https://prs-insight.online/author/Weiss%20L","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/90177","thumbnail_width":1200,"thumbnail_height":630}